For the current REF see the REF 2021 website REF 2021 logo

Output details

1 - Clinical Medicine

University of Liverpool (joint submission with Liverpool School of Tropical Medicine)

Return to search Previous output Next output
Output 313 of 480 in the submission
Article title

Pancreatic Cancer hENT1 Expression and Survival From Gemcitabine in Patients From the ESPAC-3 Trial

Type
D - Journal article
Title of journal
JNCI
Article number
-
Volume number
Advance access
Issue number
-
First page of article
-
ISSN of journal
1460-2105
Year of publication
2013
Number of additional authors
20
Additional information

a.The author made a substantial contribution to the conception and design of the study; played a major role in the organisation of the conduct of the study; supervised the conduct of the study (including acquisition of study data); played an important role in the analysis and interpretation of study data. b.The author drafted the output.

Interdisciplinary
-
Cross-referral requested
-
Research group
G - Molecular and Clinical Cancer Medicine
Citation count
-
Proposed double-weighted
No
Double-weighted statement
-
Reserve for a double-weighted output
No
Non-English
No
English abstract
-